Antiretroviral Therapy News

  • African-Americans Disproportionately Endangered by HIV/AIDS African-Americans are far more likely than other Americans to be infected with HIV but far less likely to get life-saving treatments that stop the virus’ spread, a new U.S. Centers for Disease Control and Prevention report finds.
  • U.S. FDA Approves Gilead's Biktarvy Triple HIV Drug The U.S. Food and Drug Administration on Wednesday approved Biktarvy, Gilead Sciences Inc's once-daily triple-combination tablet for treatment of HIV infection.

Antiretroviral Therapy Perspective


Antiretroviral Therapy Journal Articles